Robert Burton’s "The Anatomy of Melancholy" on the BBC


The BBC Radio 4’s In Our Time has just produced an episode about Robert Burton's 17th masterwork The Anatomy of Melancholy; the book is essentially a 17th Century multi-disciplinary investigation of what was then known as melancholy, and, as the BBC describes, brings together "almost two thousand years of scholarship, from Ancient Greek philosophy to seventeenth-century medicine. Melancholy, a condition believed to be caused by an imbalance of the body’s four humours, was characterised by despondency, depression and inactivity. Burton himself suffered from it, and resolved to compile an authoritative work of scholarship on the malady, drawing on all relevant sources."

Can't wait to give this a listen!

You can listen to the episode by clicking here. Found on the Advances in the History of Psychology website; click here to read full post.

Image: Frontspiece to Robert Burton’s The Anatomy of Melancholy, or The Anatomy of Melancholy, What it is: With all the Kinds, Causes, Symptomes, Prognostickes, and Several Cures of it. In Three Maine Partitions with their several Sections, Members, and Subsections. Philosophically, Medicinally, Historically, Opened and Cut Up, 1621

"The Immortalization Commission: Science and the Strange Quest to Cheat Death," John Gray

...“The Immortalization Commission” is a fascinating piece of intellectual history, exploring the intersection of science, religion, mysticism and a kind of philosophical curiosity that made the early 20th century so much more intellectually dynamic, so much more open-minded and eclectic, so much more magical than either philosophy or science is today. If contemporary god-builders — seeking to stave off death with blue-green algae, Bikram yoga and cryogenics — are more crass and materialistic than those in Gray’s story, ultimately they fail to appreciate the same point: that life seems to get much of its meaning from the fact that it ends. --The Scientific Revolt Against Death, review of John Gray's The Immortalization Commission, The New York Times Book Review

You can read the entire review of John Gray's fascinating The Immortalization Commission: Science and the Strange Quest to Cheat Death in today's New York Times by clicking here. You can find out more about the book--and purchase a copy--by clicking here.

Thanks, Aaron, for sending this review my way.

Image: Getty Images, captions reads:The search for eternal life: Even Charles Darwin hedged his bets and attended a seance; found at The Daily Mail.

Donate to the Making of a 19th Century Disaster Amuseument! The Cosmorama of the Great Dreamland Fire Needs Your Help!


As many of you know, I have been hard at work on an exhibition called The Great Coney Island Spectacularium, which opened just a few weeks ago at The Coney Island Museum (more on that here).

As part of the exhibition, we are--with the help of scenic painters, lighting designers and prop builders from the theater and opera world--in the midst of building a new component for the exhibition, an 19th Century-style panorama/cosmorama that will allow visitors to experience the 1911 complete destruction of Dreamland by fire in an immersive 360 degree sound, sight, and light spectacular. This component is set to premiere on May 27th, the centenary of the disaster, and is inspired by the immersive disaster spectacles so popular in Coney Island around the turn of the century.

Here's the rub: immersive amusements of this sort, as we are learning the hard way, are quite expensive to produce--probably a large reason that they were put out of business by cinema!--and we are, sadly, seriously under budget.

If 19th Century-style immersive spectacles of this sort are the kind of thing you would like to experience, and you would like to help contribute towards making this project a reality, we would be so pleased to welcome your contribution! Tax-deductable donations to Coney Island USA--our mother institution--can be made by clicking here and then hitting the "Donate" button. No amount too small! All donations appreciated.

Whether you are able to donate or not, please mark your calendar for the cosmorama opening party, which will take place on the centenary of the great disaster on Friday, May 27th, 2011. Or, come experience it later; The Comorama and the rest of The Spectacularium will be on view to the public at the Coney Island Museum until April 29th, 2012.

You can find out more about The Cosmorama by clicking here. You can join our mailing list to get updates about the opening party and other events by entering your email under "events mailing list" on the upper right hand side of the webpage. You can join our Facebook group by clicking here.

Thanks, and see you at Coney!
Joanna

Morbid Anatomy Library Seeking Volunteer(s)!


The Brooklyn-based Morbid Anatomy Library is currently seeking a volunteer to watch over the library on Saturdays from 12-6, do a bit of book cataloging, and take on assorted odd jobs. The position would begin the weekend of May 21-22; Class credit can be worked out if applicable.

For those who have not yet visited, the Library (see photo above) is an open-to-the-public research library and private collection housing books, photographs, artworks, ephemera, and artifacts relating to medical museums, anatomical art, cabinets of curiosity, death and dying, arcane media, collectors and collecting, and curiosity and curiosities broadly considered. You can find out more information about the library here.

If interested, please email me at morbidanatomy [at] gmail.com.

Thanks!

Above photo of the library by Shannon Taggart.

Annals of Eugenics Journal, 1925-1954, Now Available Online


The Annals of Eugenics--now The Annals of Human Genetics--has just made its 1925-1954 journal content available online for researchers in the history of science and medicine. Their current issue also features four specially commissioned articles that contextualizing the content, and highlighting the ways in which Eugenics "embodies the history of human genetics as a scientific enterprise and exemplifies the complex relationship of this discipline with wider society [as well as] the somber role that human genetics played in providing what was taken to be a scientific framework to social prejudice during the period."

This is sure to be some fascinating stuff.

Full details, as told by Advances in the History of Psychology:

The Annals of Human Genetics (AHG), formerly named Annals of Eugenics, has recently made its 1925-1954 journal content available online for researchers. Among the now controversial eugenics research appearing throughout these issues, researchers can also expect to find statistical publications by mathematician Karl Pearson, whose work at University College London concerned the widely used Pearson Product-Moment Correlation Coefficient, the Pearson Chi-Square test, and P-value.

The AHG editorial cites “ongoing use and reference to materials”… “and the somewhat limited availability of the original printed copy” as justification for making the content available online. Furthermore,

"Online access to the Annals of Eugenics archive will also be of interest to historians of science. In many ways, the history of the Annals embodies the history of human genetics as a scientific enterprise and exemplifies the complex relationship of this discipline with wider society. The somber role that human genetics played in providing what was taken to be a scientific framework to social prejudice during the period of “Eugenics” is a well-known case of the complex interaction between science and society. The present issue of the journal includes four specially commissioned articles that attempt to contextualize the online publication of the Annals of Eugenics archive. To exemplify some of the major scientific contributions made during that period, the article by J. Ott highlights key papers on linkage analysis published by the journal. The contributions by K. Weiss, G. Allen, and D. Kevles deal with aspects of the history of eugenics and of human genetics, and explore their relevance to ongoing debates regarding the social implications of human genetics research."

You can read the full article by clicking here.

Women Taking Calcium Supplements May Risk Heart Health, Researchers Say

(HealthDay News) -- More evidence is emerging that women who take calcium supplements to prevent bone deterioration may, in fact, be risking their heart health.

But even when added to previous studies with similar findings, the new conclusions don't necessarily mark a death knell for calcium supplements, say the authors of a study released online April 19 in the BMJ.

"There is a lack of consensus at the present time as to what recommendations should be regarding the use of calcium supplements," said study senior author Dr. Ian Reid, who fully expected that the new results will have a "significant impact on recommendations."

"Our own recommendation is to critically review the use of calcium supplements, since the data in this paper suggests that they do more harm than good," added Reid, who is professor of medicine and endocrinology at the University of Auckland in New Zealand. Read more...

AyurGold for Healthy Blood

PAML Adds Aurora Interactive’s mScope to Its Suite of Innovative Connectivity Solutions

This new partnership is dedicated to bringing cutting edge digital pathology tools to PAML and its partners and enable them to benefit from collaboration

 

SPOKANE, WASHINGTON--(Marketwire - May 4, 2011)

PAML a medical reference laboratory ranked among the top clinical reference laboratories in the United States and an industry leader in joint venture partnerships with community based hospitals and Aurora Interactive, a world leader in digital pathology communications announced today that they have signed a license agreement for Aurora's mScope digital pathology communications platform and viewer to enhance PAML's technology services offering.

"The partnership with Aurora is an important part of our commitment to the community practice of medicine and the virtue of collaboration in the medical sphere," said Dr. Tom Tiffany, PAML's CEO/President. "Our choice of a platform designed from its inception for the efficient and flexible networking of pathologists is fully consistent with our goal of providing turn-key solutions to enable competitive offerings to physicians in their local communities."

"Aurora's proven commitment to interoperability, image-type agnostic open architecture, and service culture were also key to our decision" added Mr. Sonny Varadan, Chief Information Officer.

"We firmly believe that mScope will allow us to provide our pathologist partners with best in breed communications tools they need while maintaining their freedom to choose their preferred scanning and analysis tools" said Dr. Joseph Schappert MD, Medical Director

"We are very excited about PAML's decision to include mScope in the cutting edge technology offering to its partners. We believe that PAML's vision of making it possible for pathologists to practice within their community while bringing them together virtually for better patient care is fully aligned with Aurora's commitment to collaborative pathology", stated Pierre Le Fèvre, President and Chief Executive Officer, Aurora Interactive.

About Aurora Interactive Ltd.

Aurora Interactive has developed the leading web based software platform (mScope) for simplification, productivity and ease of communications. mScope's Universal Web Viewer has collaborative tools to view medical slides and images anytime, anywhere, regardless of file format. The software has three applications to aid digital pathology web based communications needs: mScope Education, mScope Clinical, and mScope Universal Viewer. Aurora's mission is to improve patient outcomes and help members of the medical community achieve their full potential by eliminating the learning, diagnostic and collaborative restrictions imposed by time and space. http://www.aurorainteractive.com

About Pathology Associates Medical Laboratories, LLC

PAML, a full-service medical reference laboratory located in Spokane, WA, is owned by two of the nation's largest healthcare systems – Providence Health & Services (PH&S) and Catholic Health Initiatives (CHI). One of the top reference laboratories in the country, PAML is also considered an industry leader in joint venture partnerships with community-based hospitals because of their expertise in developing cutting-edge laboratory management systems, including state-of-the-art automation, and support services. PAML is a co-founder of PACLAB Network Laboratories, which provides laboratory services throughout Seattle and western Washington, and is a partner in several other hospital-based laboratory joint ventures, including Alpha Medical Laboratory (AML) serving northern Idaho; Tri-Cities Laboratory (TCL) serving central Washigton; Treasure Valley Laboratory (TVL) serving southern Idaho and northeastern Oregon; and MountainStar Clinical Laboratories (MSCL) serving Utah. For more information, visit PAML website at http://www.paml.com.

About Providence Health & Services

Providence Health & Services, California, operates five award-winning medical centers in Southern California: Providence Saint Joseph, Providence Holy Cross, Providence Tarzana, Providence Little Company of Mary Torrance and Providence Little Company of Mary San Pedro medical centers. Providence Health is a nonprofit Catholic organization dedicated to quality, compassionate care for all and to investing in the health of the communities we serve. The Providence medical centers provide a full continuum of health care services. For more information, visit http://www.providence.org.

Free Webinar – Clarient PATHSiTE Scope IA: Improving Patient Care – Powered by Definiens.

Clarient_Definiens_200px Please Join Definiens with special guest Dr. Roscoe Atkinson, M.D. from Clarient Inc. for a free webinar on May 11th, 2011 @ 11am EST:

Clarient PATHSiTE Scope IA: Improving Patient Care – Powered by Definiens.

Topics that will be covered:

- The evolution and development of Image Analysis and Scope IA at Clarient Inc.
- Clarient’s utilization of Definiens algorithms and technology
- How Clarient’s application of Scope IA and Definiens improves patient care

Speakers:

- Dr. Roscoe Atkinson, M.D. – Pathologist, Clarient
- Peter Duncan – Director, Marketing and Business Development Translational Research, Definiens

Title:    Clarient PATHSiTE Scope IA: Improving Patient Care – Powered by Definiens.
Date: Wednesday, May 11, 2011
Time: 11:00 AM – 12:00 PM EDT

Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/173191610

After registering you will receive a confirmation email containing information about joining the Webinar.

Mikroscan images to be seen

Despite mentioning MikroScan 3 times during the month of November, I inadvertently omitted mentioning them in my Year in Review post at the end of December.  While details began to come out about the size, capacity and price of the device, I did not know what scan times or image quality were and how they compared with established vendors or higher throughput devices. 

Last month someone attending the USCAP meeting sent me a text that read "They are 3 deep in the MikroScan booth".  The images I was told were of high quality with ease of use on the scanner and viewer side. 

I had to see for myself.  After accepting my offer to scan my slides complete with cracked cover slips, air bubbles, pen marks, fingerprints and coffee stains along with the tincture of time for some of the slides, the challenge was on. 

A few days later with remote viewing through join me, a simple and easy application,  I got what one would expect - a digital reproduction of every cell and the flaws on/in the slide.  Despite intentionally using non-ideal slides, the images were excellent and the artifacts, while present were no more a distraction or deterrant to viewing the slides than if I were at a microscope. 

What does this mean for the digital pathology user and laboratories?

For use cases that have a limited number of slides in an environment with limited space available (i.e. pathologist office, frozen section, cytology cart) this may just be what the doctor's doctor ordered for a rapid, reliable whole slide image that can be viewed for solo pathologist support, remote frozen section consultation between pathologists or immediate FNA interpretations.

This is not to suggest that it eliminates devices that process 4,5 or 300 or more slides with workflow and image managment software capabilities from the respective manufacturer.  I am suggesting users may need both. 

One device for the 1 or 2 slide frozen section or FNA case or limited consultation within arm's reach of a pathologist or technical assistant and a larger capacity device for large cases to be signed out, tumor boards, image analysis and archiving, likely to be centrally located where there is the greatest volume of slides and pathologists.

For more information check out http://www.mikroscan.com.

 

Lecture: Mark Dion, "My Taxidermy Taxonomy," Museum of Natural History, London, Darwin Center, Thursday May 12


My good friend Petra Lange-Berndt at University College London would like to invite all of you London-based folks out there to a free and fascinating sounding lecture--as part of an equally fascinating sounding series--by one of my favorite contemporary artists, Mark Dion.

Full details on both the lecture and the series follow; hope you can make it!

"My Taxidermy Taxonomy"
Mark Dion (Visual Artist, USA)
Venue: Museum of Natural History, London, Darwin Center, Attenborough Studio
Time: Thursday, 12 May 2011, 5pm
The lecture is free and open to all - but please phone to book tickets on
+44 (0)20 7942 5725

Mark Dion is one of the world's foremost ecological artists. He is best known for investigating and intervening into the cultures of natural history collections through site-sensitive installations. In this slide lecture Dion will examine the ways in which dominant ideologies and public institutions shape our understanding of history, knowledge, and the natural world. The artist will address more specifically the politics of taxidermy, the preservation of animal skins, and its many practices. What kind of stories, curiosities and oddities can be unearthed from the archives of the natural history museum? How is taxidermy linked to extinction and colonialism? And what is the role of the museum in contemporary society?

This lecture is part of the AHRC Research Network "The Culture of Preservation" series, at the UCL History of Art Department, run by Petra Lange-Berndt and Mechthild Fend in collaboration with the Natural History Museum London, The Hunterian Museum, and the Grant Museum of Zoology, London.

More about this series:
Prepared specimens appear in many guises: as monstrous or typical organs preserved in formaldehyde and kept in glass jars not unlike pickled food, as stained and fixed tissue slices, or as skilfully arranged stuffed animals. They may be found in cabinets of curiosities, in the laboratories of histologists, in anatomy theatres or in natural history collections, but nowadays equally in art galleries and the shop windows of fashionable boutiques. This project is concerned with such kinds of preserved natural objects, in particular with anatomical wet preparations and taxidermy. It explorses the hybrid status of these objects between nature and representation, art and science and studies their fabricaton, history and display.

Events

Workshop 1: Taxidermy: Animal Skin and Colonial Practice
12 May 2011, 5pm
Keynote Lecture – free and open to all but please telephone to book tickets on +44 (0)20 7942 5725 –

Mark Dion (Artist, New York and Pennsylvania),
My Taxidermy Taxonomy, Museum of Natural History, London, Attenborough Studio

13 May 2011 Workshop

Workshop 2: Wet Preparations: Anatomy, Pathology and the Body Contained

9 June 2011, 6 pm Keynote Lecture – free and open to all –

Nick Hopwood (Historian of Science, University of Cambridge), Human embryos: bottled, sliced and frozen, Hunterian Museum at the Royal College of Surgeons

10 June 2011 Workshop

For further information please contact Mechthild Fend m.fend(@)ucl.ac.uk or Petra Lange-Berndt p.lange-berndt(@)ucl.ac.uk

The network is a collaboration between the UCL History of Art department, UCL collections, in particular the Grant Museum of Zoology, the Hunterian Museum, London and the Natural History Museum London.

The lecture is free and open to the public, but you will need to make reservations; you can do so by calling +44 (0)20 7942 5725. You can find out more about the event and the series by clicking here.

Image: Mark Dion: An Account of Six Disastrous Years in the Library for Animals (detail), Installation at the Centrum Sztuki Wspólczesnej, Zamek Ujazdowski, Warsaw 1992

Mental 'Exercise' May Only Hide Signs of Alzheimer's

(HealthDay News) -- Reading, crossword puzzles and other mentally stimulating activities have pros and cons when it comes to Alzheimer's disease, new research suggests.

In line with prior research, the study finds that such mental activity may slow declines in thinking and memory during normal old age.

But folks who loved these pursuits actually displayed a hastening of their mental decline once symptoms of dementia began to set in, the researchers say.

"We think there's a trade-off," said senior study author Robert Wilson of Rush University Medical Center in Chicago. Keeping mentally active means that there is "a little more time during which the person is cognitively competent and independent and a little less time in a disabled and dependent state" once dementia does set in, said Wilson, who is senior neuropsychologist at Rush's Alzheimer's Disease Center.

The findings were published online Sept. 1 in Neurology.

Previous work has suggested that engaging in cognitively challenging activities may help ward off the appearance of dementia in older people. To test this, Wilson and his co-workers tracked almost 1,200 older individuals over nearly 12 years. Read more...

ClariMind Memory & Concentration Supplement

2011 ASCP Annual Meeting/WASPaLM XXVI World Congress – Abstract Deadline Near

  • Submissions cannot have been presented, published, or submitted for presentation or publication elsewhere.
  • All abstracts must be submitted electronically by April 29, 2011. Late abstracts, or those received by any means other than the ASCP abstract submission website will not be reviewed by ASCP.
  • Abstracts must be submitted in English. Submitting an abstract does NOT guarantee its acceptance at the 2011 ASCP Annual Meeting/WASPaLM XXVI World Congress. ASCP will provide notification of final status to all abstract submissions by July 1, 2011.
  • Particular attention should be given to products or equipment that bear registered trade names. Provide the company name and its city and state address parenthetically following the first mention of the product.
  • References should not be used. No charts, figures, or tables should be used.
  • Notice of acceptance will be sent via e-mail only. When setting up your user account, please use all fields for author and administrative support so that you will receive notices in a timely manner.
  • An initial confirmation e-mail will inform you of the receipt of your submission.
  • Authors will be notified in late summer of their status as a finalist in a poster competition, selection for an oral platform presentation, or poster session day and time assignment.
  • All submitted abstracts will be peer reviewed. Refer to the “Abstract Submission Guidelines” for grading criteria and other details of the abstract submission process.
  • For further information please e-mail us at abstracts@ascp.org or call 312-541-4943.

You may download a PDF copy of the abstract submission guidelines by clicking here.

Ronald Reagan UCLA Medical Center Uses Aperio’s Digital Pathology System to Provide Anatomic Pathology Consulting Services to China

30 UCLA Sub-Specialty Pathologists Available to Second Affiliated Hospital Zhejiang University

Vista, CA – April 26, 2011 - Aperio, the global leader in providing digital pathology solutions that improve patient care, today announced that its digital pathology system is being used to support subspecialty pathology consultations between Ronald Reagan UCLA Medical Center (UCLA) in Los Angeles, Calif., and Second Affiliated Hospital Zhejiang University, (ZHU) a 2,000-bed top-ranked hospital located in Hangzhou, China. 

UCLA has a pool of more than 30 sub-specialty experts in pathology that are available to provide remote medical consultation services to China for unusual and complex cases. Aperio’s patented scanning technology allows pathologists at ZHU to capture a digital slide image at very high resolution of the entire tissue sample on a glass slide and share it with pathology experts at UCLA in a secure web-based environment. More than 100 cases have been remotely reviewed to date. The Aperio digital pathology system facilitates the ability to bring high-quality, expert pathology services to China, significantly improving intra and inter observer agreement and ensuring effective treatment to improve patient care. 

“UCLA and ZHU selected the only true global leader in digital pathology that can deliver a complete remote consultation capability today,” said Dirk G. Soenksen, CEO of Aperio. “Aperio is helping healthcare organizations of all types deliver sub-specialty pathology services via online access to topnotch virtual pathologists. Pathology expertise is just a mouse click away anywhere in the world to help ensure the best pathology services possible in a fast and cost-effective way.” 

Use of Aperio’s patented ScanScope® scanners, Spectrum™ image management (PACS) software and remote viewing technology allows U.S. healthcare companies to compete at an international level, facilitating real-time, high performance access to high-resolution digital slide images. 

Jonathan Braun, M.D., Ph.D., chair of pathology and laboratory medicine, and professor of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, stated, “Digital pathology allows UCLA to offer the advanced skills of our sub-specialty pathologists to China in real time when a specific type of pathology expertise is needed quickly on a difficult or complex case. Our collaboration illustrates how integral pathology is to patient outcomes. Pathologists have become influential partners in treatment. Digital pathology dramatically enhances our ability to provide patient-centered care.” 

UCLA and ZHU pathologists also participate in frequent digital slide conferences using the Aperio system to review individual cases. Pathologists can view annotations on the digital slide image created by other reviewers, while simultaneously adding annotations for others to see. A common cursor superimposed on the digital slide is visible and can be manipulated by all conference participants. The hospitals are also conducting multi-disciplinary conferences, where experts across various disciplines (oncology, radiology, surgery) convene to discuss difficult cases. 

With more system installations than all other digital pathology vendors combined, Aperio is the true global leader and reliable choice for world class digital pathology solutions. The company boasts a global installed base of more than 800 systems in over 30 countries, including more than 500 systems in hospitals and reference laboratories, the 13 largest pharmaceutical companies and a multitude of biotechnology and government organizations.  

 

Exhibitors Sought for the Pathology Informatics 2011 Conference in Pittsburgh

We are seeking exhibitors for the Pathology Informatics 2011 conference that will take place at the Wyndham Hotel in Pittsburgh on October 4-7, 2011. This conference resulted from a merger of two previous pathology informatics conferences, Lab Infotech Summit and APIII. The inaugural merged conference was held in Boston last September. A total of 41 exhibitors participated in that event with about 250 paid registrants in attendance.

via labsoftnews.typepad.com

Regional Healthcare Event Series by Aperio — Atlanta, Philadelphia & Baltimore this May

Join us for the 2011
“Discover Your Path to Improved Patient Care”
Regional Healthcare Event Series

featuring Jared N. Schwartz, M.D., Ph.D., 
Aperio technical experts, and leading innovators who will
discuss how they are using digital pathology.


May 17 ~ Atlanta, GAHealthcare Regional Events
Seminar Event
 
May 18 ~ Philadelphia, PA
User Group*
 
May 19 ~ Baltimore, MD
Seminar Event


All events are complimentary and include validated parking, breakfast, and lunch.

Topics vary by location and include:

• Digital Pathology Beyond the Scan: Improving Patient Care and Enabling Personalized Medicine 

• Tips and Tricks for Spectrum Plus and ScanScopes

• Phased Adoption: Helping Hospitals Implement Digital Pathology

• Global Research Collaboration in a Shrinking World - Unlocking the Possibilities

• Virtual Microscopy Meets Next Generation Sequencing: Strange Bedfellows in the Genomic Age

• From Teaching to Research - Practical Use of Aperio in an Academic Institution

• Selected Topics in Image Analysis for IHC

• Special Local Area Speaker Sessions

• Roundtable Discussions


RSVP TODAY TO RESERVE YOUR SEAT!
To RSVP for any of these events, contact Nicole Siska, Aperio Events Team, at 760.539.1193 or nsiska@aperio.com

*The May 18 Philadelphia event is intended for Aperio users who have a working knowledge of the Aperio system. 

Philips and NEC Team Up in Digital Pathology

This sounds interesting -- combination of high-end imaging system from Philips with added quantitation tools provided by NEC.  According to the press release, look for results of this partnership by years' end.
 
Eindhoven, the Netherlands and Tokyo, Japan – Royal Philips Electronics (NYSE: PHG, AEX: PHI) and NEC Corporation (NEC; TSE: 6701) today announced the signing of an agreement under which the two companies will jointly develop and market highly integrated digital pathology solutions. Based around Philips’ new high-throughput pathology slide scanner and NEC’s e-Pathologist Cancer Diagnosis Assistance System, these innovative digital pathology solutions will be designed to use advanced digital techniques to add quantitative analysis to the qualitative information derived from the visual inspection of pathology slides, which is currently the standard procedure. They will initially be targeted to assist in the grading of breast cancer and prostate cancer.
 
Whenever a lesion is suspected to be cancerous or pre-cancerous, the normal procedure is to remove a sample of tissue from it (a biopsy) and send it to a pathology lab for examination by a pathologist. To conduct this examination, a thin section of the tissue is mounted on a glass slide, stained with chemicals to highlight various structures and visually examined under a microscope. With the increasing incidence of cancer and the growing need for methods of sub-typing the disease in order to deliver optimized therapy, there is a real need for digital pathology systems that speed up the workflow, while also providing pathologists with additional checks to improve diagnostic quality and specificity.
 
“Reliable computer-aided identification of regions of interest, based on the morphology of potentially cancerous cells in stained tissue samples, clearly depends on having high quality images to work with,” says Tadashi Higashino, Senior Vice President at NEC. “We firmly believe that the continuous auto-focus technology developed by Philips for use in its slide scanners will provide exceptional image detail and quality, allowing our advanced image analysis and machine learning algorithms to achieve optimum results.”
 
“With its e-Pathology system, NEC already has an impressive position in the digital pathology market in Japan and is well positioned to duplicate that success in many other parts of the world,” says Perry van Rijsingen, Senior Vice President and General Manager, Philips Healthcare Incubator. “I believe our joint development of highly integrated systems that combine superior slide scanning with state-of-the-art image analysis will be essential to unlocking the growth potential of digital pathology by helping to meet the ever-increasing demand for high-volume high-throughput pathology solutions.”
 
Philips’ ultra-fast slide scanner, which is already commercially available only in Europe for research purposes, employs a unique ‘continuous auto-focus’ technology that accurately follows height variations in the tissue surface over horizontal distances as short as 30 microns, allowing extremely high definition full-slide images to be captured in under one minute per slide.

NEC’s e-Pathologist system will use ‘machine intelligence’ to detect tissue and cell features within these images in order to identify regions of interest and make quantitative measurements of key structures in conventionally stained (Hematoxylin & Eosin) tissue samples, or samples stained with immunohistochemistry reagents. These quantitative measurements could assist pathologists in making decisions relating to the clinical treatment of cancer in individual patients. NEC has jointly evaluated this system with SRL, Inc., the largest laboratory test center in Japan, for biopsy of stomach cancer and has also started marketing a system focused on stomach and breast cancer. In addition, NEC has jointly evaluated its e-Pathologist system with the Massachusetts General Hospital (MGH) in the USA.

“As a leader in medical innovation, Massachusetts General Hospital Pathology has long been committed to utilizing imaging and data analysis for diagnosis and discovery. Digital pathology and diagnostic imaging analysis are obviously important areas of development driving such innovation,” said Dr. David Louis, Chief of Pathology at MGH. “

We are pleased to have been involved in the development of the Philips high throughput scanner and the NEC e-Pathologist system and look forward to the next phase of their development."

The digital pathology solution of Philips features an open architecture that allows partners/vendors to expand the system’s capability by integrating their own added-value hardware and/or software algorithms into it. This will allow the creation of total system solutions designed to empower pathologists by delivering increased workflow efficiency, improved diagnostic performance and better patient outcomes. Partnering with Philips, a world leading company in healthcare markets, will therefore help NEC to develop its technology to suit worldwide market requirements.
 

Philips and NEC aim to produce initial development results from their joint development in digital pathology within the current year.

Dr. David Eberhard joins Flagship Biosciences as Chief Medical Pathologist

Pharmaceutical veteran anatomic pathologist strengthens Flagship's expertise in oncology and clinical trials

Flagstaff, AZ (04/26/2011) —Flagship Biosciences announced today that Dr. David Eberhard MD, PhD has been appointed Chief Medical Pathologist. Dr. Eberhard is an anatomic/molecular pathologist highly regarded for his leadership and expertise in oncology clinical trials and pharmaceutical drug development. He holds an academic appointment as Associate Professor, Department of Pathology and the Lineberger Comprehensive Cancer Center, at the University of North Carolina at Chapel Hill. Previously, he served as the Director of Clinical Trials Pathology Services at LabCorp’s Center for Molecular Biology and Pathology, after a distinguished career at Genentech and as an industry consultant. He earned his MD in Pathology and his Ph.D. in pharmacology from the University of Michigan Medical School, followed by residency training in anatomic pathology and neuropathology at the University of Virginia School of Medicine.

Dr. Eberhard has been active in developing standardized approaches for molecular pathologic analyses of solid tumors in clinical trials, such as the publication of industry working group recommendations for EGFR testing in pathology. “The addition of Dr. Eberhard to Flagship’s pathology and development team further strengthens our position as a leader in qualitative and quantitative digital pathology.” said Dr. David Young, President of Flagship Biosciences.“He has been a steady encouragement from the beginnings of Flagship and has a great vision for applications of image analysis in both research and clinical medicine”. 

David Eberhard has served on the Scientific Advisory Board for Flagship Biosciences, and in his new expanded role will strengthen the collaboration provided by Flagship’s network of anatomic pathologists of various specializations in the United States and Europe, and facilitate closer interactions and innovation between Flagship’s new quantitative pathology approaches, academic investigation and oncology drug development. 

“Flagship has a unique focus on cutting-edge digital pathology approaches to maximize efficiency of anatomic pathology analyses, to allow precise, accurate and reproducible quantitation of pathology readouts, and to support the clinical development of drugs and companion diagnostics” said Dr. Eberhard. "Flagship's perspective and expertise represent a valuable resource for basic, translational and clinical R&D that has huge potential to create real progress in science and industry."

Flagship Biosciences is a pathologist-owned pharmaceutical services organization that specializes in the delivery of quantitative pathology to pharmaceutical, biotech, and medical device clients. Flagship leverages digital pathology to combine novel quantitative scoring algorithms with anatomic pathology expertise and experience. They are the largest provider of pathologist-supervised brightfield and fluorescence scanning and custom image analysis capabilities.

 

Proposed Accountable Care Organization Regulations

On April 7, 2011, the Centers for Medicare & Medicaid Services ("CMS") issued its proposed regulations covering Accountable Care Organizations ("ACOs"). When adopted in final form, this rule will implement Section 3022 of the Patient Protection and Affordable Care Act, which requires CMS to establish a Shared Savings Program by January 1, 2012. These proposed regulations are the first in a series, and set forth the basic eligibility requirements for ACOs to participate in the Shared Savings Program; quality of care and other reporting measures; the methodology for assigning Medicare beneficiaries to ACOs; the payment methodologies under the Shared Savings Program; monitoring of ACOs for compliance with applicable criteria; and the sanctions for non-compliance. Comments regarding the proposed regulations are due by June 6, 2011. This alert is intended to provide only a high level summary of the proposed regulations.

The proposed regulations define an ACO as a legal entity recognized to conduct business under state law, with a governance structure that will enable it to receive and distribute shared savings, establish and report compliance with the ACO quality and reporting requirements, and perform other tasks set forth in the regulations. An ACO may be established by: (a) professionals in group practices, (b) networks of individual practices, (c) ventures between hospitals and professionals, (d) hospitals who employ professionals, and (d) critical access hospitals. Other health care providers and suppliers may participate in an ACO, but they cannot establish an ACO. It is important to note that primary care professionals (which include professionals in the specialties of general practice, family practice, internal medicine or geriatric medicine) can only be ACO participants in a single ACO, whereas other types of providers, such as specialist physicians, may participate in multiple ACOs.    

Click here for full text of the alert.

Courtesy of McDonald Hopkins